Wong H - Search Results

1

Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.

Smalls-Mantey A, Doria-Rose N, Klein R, Patamawenu A, Migueles SA, Ko SY, Hallahan CW, Wong H, Liu B, You L, Scheid J, Kappes JC, Ochsenbauer C, Nabel GJ, Mascola JR, Connors M. Smalls-Mantey A, et al. Among authors: wong h. J Virol. 2012 Aug;86(16):8672-80. doi: 10.1128/JVI.00287-12. Epub 2012 Jun 6. J Virol. 2012. PMID: 22674985 Free PMC article.

2

Targeting activity of a TCR/IL-2 fusion protein against established tumors.

Wen J, Zhu X, Liu B, You L, Kong L, Lee HI, Han KP, Wong JL, Rhode PR, Wong HC. Wen J, et al. Cancer Immunol Immunother. 2008 Dec;57(12):1781-94. doi: 10.1007/s00262-008-0504-7. Epub 2008 Mar 28. Cancer Immunol Immunother. 2008. PMID: 18369620 Free PMC article.

3

In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Seay K, Church C, Zheng JH, Deneroff K, Ochsenbauer C, Kappes JC, Liu B, Jeng EK, Wong HC, Goldstein H. Seay K, et al. Among authors: wong hc. J Virol. 2015 Jun;89(12):6264-74. doi: 10.1128/JVI.00563-15. Epub 2015 Apr 1. J Virol. 2015. PMID: 25833053 Free PMC article.

4

Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein.

Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JH, Wong H, Jeng E, Jones J, Ochsenbauer C, Kappes JC, Dimitrov DS, Ying T, Goldstein H. Bardhi A, et al. Among authors: wong h. J Virol. 2017 Sep 27;91(20):e00937-17. doi: 10.1128/JVI.00937-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28794022 Free PMC article.

5

In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein.

Mosquera LA, Card KF, Price-Schiavi SA, Belmont HJ, Liu B, Builes J, Zhu X, Chavaillaz PA, Lee HI, Jiao JA, Francis JL, Amirkhosravi A, Wong RL, Wong HC. Mosquera LA, et al. J Immunol. 2005 Apr 1;174(7):4381-8. doi: 10.4049/jimmunol.174.7.4381. J Immunol. 2005. PMID: 15778403

6

Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules.

Wong RL, Liu B, Zhu X, You L, Kong L, Han KP, Lee HI, Chavaillaz PA, Jin M, Wang Y, Rhode PR, Wong HC. Wong RL, et al. Protein Eng Des Sel. 2011 Apr;24(4):373-83. doi: 10.1093/protein/gzq116. Epub 2010 Dec 21. Protein Eng Des Sel. 2011. PMID: 21177283 Free PMC article.

7

Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma.

Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD, Rubinstein MP, Rhode PR, Wong HC. Xu W, et al. Cancer Res. 2013 May 15;73(10):3075-86. doi: 10.1158/0008-5472.CAN-12-2357. Epub 2013 May 3. Cancer Res. 2013. PMID: 23644531 Free PMC article.

8

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.

Rhode PR, Egan JO, Xu W, Hong H, Webb GM, Chen X, Liu B, Zhu X, Wen J, You L, Kong L, Edwards AC, Han K, Shi S, Alter S, Sacha JB, Jeng EK, Cai W, Wong HC. Rhode PR, et al. Among authors: wong hc. Cancer Immunol Res. 2016 Jan;4(1):49-60. doi: 10.1158/2326-6066.CIR-15-0093-T. Epub 2015 Oct 28. Cancer Immunol Res. 2016. PMID: 26511282 Free PMC article.

9

ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.

Ellis-Connell AL, Balgeman AJ, Zarbock KR, Barry G, Weiler A, Egan JO, Jeng EK, Friedrich T, Miller JS, Haase AT, Schacker TW, Wong HC, Rakasz E, O'Connor SL. Ellis-Connell AL, et al. J Virol. 2018 Jan 17;92(3):e01748-17. doi: 10.1128/JVI.01748-17. Print 2018 Feb 1. J Virol. 2018. PMID: 29118125 Free PMC article.

10

An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.

Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY. Fantini M, et al. Cancer Biother Radiopharm. 2019 Apr;34(3):147-159. doi: 10.1089/cbr.2018.2628. Epub 2019 Jan 2. Cancer Biother Radiopharm. 2019. PMID: 30601063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,085 results

Search Page

Filters